Clinuvel Pharmaceuticals
CUV.AX
#7502
Rank
S$0.53 B
Marketcap
S$10.69
Share price
1.78%
Change (1 day)
10.53%
Change (1 year)

Earnings for Clinuvel Pharmaceuticals (CUV.AX)

Earnings in 2025: S$43.15 Million

According to Clinuvel Pharmaceuticals's latest financial reports the company's current earnings are S$62.5 Million. In 2025 the company made an earning of S$43.15 Million, an increase over its 2024 earnings that were of S$43.04 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Clinuvel Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025S$43.15 M0.26%
2024S$43.04 M11.35%
2023S$38.65 M28.31%
2022S$30.12 M22.8%
2021S$24.53 M112.63%
2020S$11.53 M-28.73%
2019S$16.19 M32.79%
2018S$12.19 M75.41%
2017S$6.95 M-332.52%
2016-S$2.99 Million-70.68%
2015-S$10.2 Million53.78%
2014-S$6.64 Million-16.1%
2013-S$7.91 Million-37.92%
2012-S$12.74 Million-18.19%
2011-S$15.57 Million25.31%
2010-S$12.42 Million-21.53%
2009-S$15.83 Million-11.27%
2008-S$17.84 Million80.4%
2007-S$9.89 Million-2.46%
2006-S$10.14 Million-5.35%
2005-S$10.72 Million60.55%
2004-S$6.68 Million97.37%
2003-S$3.38 Million50.62%
2002-S$2.25 Million121.22%
2001-S$1.02 Million254.48%
2000-S$0.29 Million